CSDX Stock Chart & Stats
$0.10
-$0.05(-2.70%)
At close: 4:00 PM EST
$0.10
-$0.05(-2.70%)
Day’s Range― - ―
52-Week Range$0.03 - $0.40
Previous CloseN/A
Volume103.00
Average Volume (3M)9.20K
Market Cap
$8.25M
Enterprise Value$10.39M
Total Cash (Recent Filing)$6.81K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)82.5
Beta-1.92
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding249,992,200
10 Day Avg. Volume11,192
30 Day Avg. Volume9,198
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.15
Price to Sales (P/S)374.87
P/FCF Ratio12.12K
Enterprise Value/Market Cap1.26
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-146.06
Enterprise Value/Ebitda145.91
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CS Diagnostics News
CSDX FAQ
What was CS Diagnostics’s price range in the past 12 months?
CS Diagnostics lowest stock price was $0.03 and its highest was $0.40 in the past 12 months.
What is CS Diagnostics’s market cap?
CS Diagnostics’s market cap is $8.25M.
When is CS Diagnostics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CS Diagnostics’s earnings last quarter?
Currently, no data Available
Is CS Diagnostics overvalued?
According to Wall Street analysts CS Diagnostics’s price is currently Overvalued.
Does CS Diagnostics pay dividends?
CS Diagnostics does not currently pay dividends.
What is CS Diagnostics’s EPS estimate?
CS Diagnostics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CS Diagnostics have?
CS Diagnostics has 249,992,200 shares outstanding.
What happened to CS Diagnostics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CS Diagnostics?
Currently, no hedge funds are holding shares in CSDX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CS Diagnostics
Headquartered in Neuss, Germany, CS Diagnostics Corp. was established in 1996. The company is dedicated to the development, production, and worldwide distribution of a range of health and medical-grade products, catering to both domestic German and international markets. Among its key offerings are MEDUSA, an exclusive surface disinfectant, and CS-Protect Hydrogel, a specialized tissue-spacing gel for radiation therapy applications. The firm rebranded as CS Diagnostics Corp. in August 2023, having previously operated under the name FlashZero Corp.
Technical Analysis
Tempest Therapeutics
―
Actinium Pharmaceuticals
―
PDS Biotechnology
―
OnKure Therapeutics
―
Xilio Therapeutics
―